Skip to Main Content
Contribute Try STAT+ Today

In the latest indication of how some people are struggling to afford their medicines, a new survey finds that 18% of people who have diabetes around the world rationed their insulin at least once last year, but this occurred among nearly 26% of people with diabetes in the U.S.

And while 70% reported having some coverage for their costs, two-thirds noted they have no financial support for the remaining out-of-pocket costs. In the U.S., 89% of people with diabetes had health care coverage, but 79% had no other form of assistance. Just 5.5% received government assistance, according to the survey by T1International, a patient advocacy group that focuses on Type 1 diabetes.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.